Koers Phytopharm plc London S.E.
Aandelen
GB0006869720
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- GBX | - |
Omzet 2024 * | 5,2 mln. 6,49 mln. 6,04 mln. | Omzet 2025 * | - | Marktkapitalisatie | 3,93 mln. 4,91 mln. 4,57 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -2 mln. -2,5 mln. -2,33 mln. | Nettowinst (verlies) 2025 * | - | EV/omzet 2024 * | 0,49 x |
Nettoliquiditeiten 2024 * | 1,4 mln. 1,75 mln. 1,63 mln. | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-1,48
x | K/w-verhouding 2025 * |
-
| Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 51,17% |
Recentste transcriptie over Phytopharm plc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Giulio Cerroni
CEO | Chief Executive Officer | 63 | 06-02-17 |
Director of Finance/CFO | 47 | 31-05-19 | |
Charles Spicer
CHM | Chairman | 59 | 14-10-13 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Charles Spicer
CHM | Chairman | 59 | 14-10-13 |
Director/Board Member | 49 | 16-09-16 | |
Dipti Amin
BRD | Director/Board Member | 60 | 05-10-23 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+21,74% | 46,4 mld. | |
-0,97% | 41,75 mld. | |
+47,07% | 41,37 mld. | |
-3,52% | 29,71 mld. | |
+11,12% | 26,01 mld. | |
-19,37% | 19,52 mld. | |
+31,18% | 12,43 mld. | |
-0,04% | 12,13 mld. | |
+0,39% | 12,18 mld. |